tiprankstipranks
Trending News
More News >

BioMark Advances Cancer Detection with Biomarker Study

Story Highlights
BioMark Advances Cancer Detection with Biomarker Study

BioMark Diagnostics (TSE:BUX) has released an update.

Confident Investing Starts Here:

BioMark Diagnostics Inc. has made strides in cancer detection by publishing a study on identifying metabolomic biomarkers for pulmonary neuroendocrine neoplasms (NENs), which could enhance early diagnosis and patient management. Their liquid biopsy technology shows potential for non-invasive, cost-effective, and accurate detection of NENs and other cancers, funded by a MEDTEQ+ research grant.

For further insights into TSE:BUX stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App